Ironwood Pharmaceuticals (IRWD) Q2 2012 Earnings Call July 17, 2012 8:30 am ET Executives Meredith Kaya Michael J. Higgins - Chief Financial Officer, Chief Operating Officer, Principal Accounting Officer and Senior Vice President Thomas A. McCourt - Chief Commercial Officer and Senior Vice President of Marketing & Sales Mark G. Currie - Chief Scientific Officer and Senior Vice President of Research & Development James M. DeTore - Vice President of Finance and Administration Analysts Geoffrey C. Meacham - JP Morgan Chase & Co, Research Division Graig Suvannavejh - Jefferies & Company, Inc., Research Division Raghuram Selvaraju Gregory R. Wade - Wedbush Securities Inc., Research Division Juan F. Sanchez - Ladenburg Thalmann & Co. Inc., Research Division Rachel L. McMinn - BofA Merrill Lynch, Research Division Mario V. Corso - Caris & Company, Inc., Research Division Irina Rivkind - Cantor Fitzgerald & Co., Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Ironwood Pharmaceuticals Second Quarter 2012 Investor Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to introduce your host, Meredith Kaya. Please go ahead. Meredith Kaya Good morning, and thank you for joining us for our second quarter 2012 investor update. Joining me for today's call is Michael Higgins, our Chief Operating Officer. We also have Peter Hecht, our Chief Executive Officer; Mark Currie, our Chief Scientific Officer; Tom McCourt, our Chief Commercial Officer; and Jim DeTore, our Vice President of Finance, available for the question-and-answer portion of the call. By now, you should have a copy of our press release which crossed the wire earlier this morning. If you need a copy of the press release, you can go to our website, www.ironwoodpharma.com, to find an electronic copy.